Coronary Artery Disease
Coronary artery disease (CAD) occurs when the coronary arteries become narrowed or blocked, reducing blood flow to the heart. This can lead to chest pain, heart attacks, and other serious heart problems.
Colchicine for Heart Health After PCI
We are studying whether colchicine can help reduce serious heart events in patients with coronary artery disease after a heart procedure. This trial compares colchicine to a placebo to see its effects on heart health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 45 years old or older?
- Do you have coronary artery disease (heart disease) that has been treated with a procedure called PCI?
- Are you currently pregnant, breastfeeding, or not using effective birth control?
- Are you taking any strong medications like clarithromycin, ketoconazole, or cyclosporine?
- Have you had any major surgery or medical event in the past month?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Colcamedin
Colcamexx
Colchanova
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Algemeen Stedelijk Ziekenhuis Campus Aalst
Cardiology
Aalst, Belgium
Het Ziekenhuisnetwerk Antwerpen
Cardiology
Berchem, Belgium
UZ Brussel
Cardiology
Ganshoren, Belgium
Sponsor: Universitair Ziekenhuis Gent
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.